Evidence map›Paper›PMID 37981995›Full record

ArticleTetrahedron2023

Chemoenzymatic Synthesis of

Hai Yu, Zimin Zheng, Libo Zhang, Xiaohong Yang, Ajit Varki, Xi Chen

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Tetrahedron, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hai YuDepartment of Chemistry, University of California, Davis, California, 95616, USA.
Zimin ZhengDepartment of Chemistry, University of California, Davis, California, 95616, USA.
Libo ZhangDepartment of Chemistry, University of California, Davis, California, 95616, USA.
Xiaohong YangDepartment of Chemistry, University of California, Davis, California, 95616, USA.
Ajit VarkiDepartments of Medicine and Cellular & Molecular Medicine, Glycobiology Research and Training Center, University of California, San Diego, California, 92093, USA.
Xi ChenDepartment of Chemistry, University of California, Davis, California, 95616, USA.
University of California, Davis · USUniversity of California San Diego · US

Funding

BIOSYNTHESIS AND REGULATION OF SUBSTITUTED SIALIC ACIDSR01GM032373 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI VARKI, AJIT P · 1985 to 2022
$6.9M
Facile chemoenzymatic synthesis and purification of glycolipidsU01GM120419 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHEN, XI · 2016 to 2019
$2.8M
Developing chemoenzymatic strategies, enzymes, and kits for accessible and affordable gangliosidesR44GM139441 · NIGMS · INTEGRATED MICRO-CHROMATOGRAPHY SYSTEMS, INC. · PI LEE, LIM ANDREW · 2020 to 2022
$2.7M
Supplement: Exploring the biology of O-acetyl sialic acids using stable synthetic mimicsR01AI130684 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHEN, XI, VARKI, AJIT P · 2017 to 2020
$2.3M
Acquisition of a Q-Exactive Plus Mass SpectrometerS10OD025271 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI JEWELL, WILLIAM T · 2019 to 2019
$486k
NIAID NIH HHS R01 AI130684NIGMS NIH HHS R01 GM032373NIGMS NIH HHS R44 GM139441NIGMS NIH HHS U01 GM120419NIH HHS S10 OD025271
6 · The paper itself

Abstract

The stable

Indexed as

9-N-acetyl sialic acidb-series gangliosidechemoenzymatic synthesisglycosphingolipidO-acetyl sialic acidone-pot multienzyme

Identifiers

PMID37981995
PMCPMC10653377
OpenAlexW4380996362

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.